Skip to main content
Clinical Trials/NCT03703193
NCT03703193
Completed
Not Applicable

Dry Needling for Shoulder Pain and Presence of Post-needling Induced-Pain in PAtients Who Had Suffered a Stroke

Universidad Rey Juan Carlos1 site in 1 country16 target enrollmentOctober 19, 2018
ConditionsStroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
Universidad Rey Juan Carlos
Enrollment
16
Locations
1
Primary Endpoint
Changes in post-dry needling pain intensity with a numerical pain rate scale before and after the intervention
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Spasticity and pain, particularly int he shoulder region, are the most common impairments experienced by subjects who had experienced a stroke. There is preliminary evidence supporting the role of dry needling for spasticity in patients who had suffered from a stroke. Few data exists on the effects on shoulder pain. In addition, it has been shown that application of dry needling induces post-needling soreness in individuals with musculoskeletal pain. No previous study has investigated the presence and the duration of post-needling soreness in individuals who had experienced a stroke.

Registry
clinicaltrials.gov
Start Date
October 19, 2018
End Date
December 21, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

César Fernández-de-las-Peñas

Director of Department

Universidad Rey Juan Carlos

Eligibility Criteria

Inclusion Criteria

  • first-ever unilateral stroke;
  • hemiplegia resulting from stroke;
  • age between 30 and 60 years old;
  • presence of hypertonicity in the upper extremity;
  • pain symptoms in the shoulder
  • active trigger points in the shoulder muscles reproducing the shoulder pain symptoms

Exclusion Criteria

  • recurrent stroke;
  • absence of active trigger points in the shoulder muscles reproducing shoulder symptoms
  • previous treatment with nerve blocks, motor point injections with neurolytic agents for spasticity at any time;
  • previous treatment with botulinum toxin-A in the 6 months prior the study;
  • severe cognitive deficits;
  • other neurologic diseases,
  • underlying complex medical conditions, e.g., heart conditions, unstable hypertension, fracture
  • fear to needles;
  • any contraindication for deep dry needling, e.g., anticoagulants, infections, bleeding, or psychotic.

Outcomes

Primary Outcomes

Changes in post-dry needling pain intensity with a numerical pain rate scale before and after the intervention

Time Frame: Baseline, 24 hours (1 day) after and 72 hours (3 days) after treatment the intervention

A Numerical Pain Rate Scale (NPRS, 0-10) will be used to record post-dry needling soreness in the targeted area

Secondary Outcomes

  • Presence of active trigger points in the shoulder musculature(Baseline, 72 hours (3 days) and 168 hours (7 days) after treatment the intervention)
  • Changes in spontaneous shoulder pain with a numerical pain rate scale before and after the intervention(Baseline, 72 hours (3 days) and 168 hours (7 days) after treatment the intervention)

Study Sites (1)

Loading locations...

Similar Trials